Acute viral nasopharyngitis cost-effectiveness of therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
==Cost-Effectiveness of Therapy== | ==Cost-Effectiveness of Therapy== | ||
* In the USA alone, the common cold leads to 75 to 100 million physician visits annually at a conservative cost estimate of $7.7 billion per year. | * In the USA alone, the common cold leads to 75 to 100 million physician visits annually at a conservative cost estimate of $7.7 billion per year. | ||
| Line 14: | Line 13: | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Viruses]] | |||
[[Category:Viral diseases]] | |||
[[Category:Inflammations|Nasopharyngitis]] | |||
[[Category:Infectious disease]] | |||
[[Category:Pulmonology]] | |||
Revision as of 14:34, 1 November 2012
|
Acute viral nasopharyngitis Microchapters |
|
Differentiating acute viral nasopharyngitis from other diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Acute viral nasopharyngitis cost-effectiveness of therapy On the Web |
|
American Roentgen Ray Society Images of Acute viral nasopharyngitis cost-effectiveness of therapy |
|
FDA on Acute viral nasopharyngitis cost-effectiveness of therapy |
|
CDC on Acute viral nasopharyngitis cost-effectiveness of therapy |
|
Acute viral nasopharyngitis cost-effectiveness of therapy in the news |
|
Blogs onAcute viral nasopharyngitis cost-effectiveness of therapy |
|
Risk calculators and risk factors for Acute viral nasopharyngitis cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Cost-Effectiveness of Therapy
- In the USA alone, the common cold leads to 75 to 100 million physician visits annually at a conservative cost estimate of $7.7 billion per year.
- Americans spend $2.9 billion on over-the-counter drugs and another $400 million on prescription medicines for symptomatic relief.
- More than one-third of patients who saw a doctor received an antibiotic prescription, which not only contributes to unnecessary costs ($1.1 billion annually on an estimated 41 million antibiotic prescriptions in the United States), but also has implications for antibiotic resistance from overuse of such drugs.
- An estimated 22 to 189 million school days are missed annually due to a cold. As a result, parents missed 126 million workdays to stay home to care for their children.
- When added to the 150 million workdays missed by employees suffering from a cold, the total economic impact of cold-related work loss exceeds $20 billion.